key: cord-1030563-2ghb1gra
authors: Lebowitz, Emily; Kim, Joshua Seokju; Magro, Cynthia
title: Reactive arthritis following COVID-19 vaccination with BNT162b2
date: 2022-05-11
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2022.04.026
sha: 22794e2d0cab1c4b8a9108b77f1cff3f9a988cb7
doc_id: 1030563
cord_uid: 2ghb1gra

nan

I confirm that official permission and consent have been obtained to publish all the figures included in this publication.

I attest that all authors listed on the title page have read the manuscript. All the authors listed attest to the data presented and agree to its submission. All conflicts of interest and sources of financial support have been reported. The authors have no conflicts of interest or sources of financial support to disclose.

In this publication, we present a unique case of reactive arthritis (Reiter's syndrome) favored to be triggered by the Pfizer COVID-19 vaccine. We have made edits (highlighted in yellow) and we've attached a word document with responses to the reviewers' comments. Reactive arthritis (RA), or Reiter's syndrome, is a rare disease that is characterized by a triad of 25 urethritis, conjunctivitis and arthritis, typically secondary to an extra-articular infection of the 26 genitourinary or gastrointestinal tract. 1 Often there is significant variation in clinical features and 27 patients may present with mucocutaneous findings such as oral lesions, circinate balanitis, 28 keratoderma blenorrhagicum and nail dystrophy. 1 HLA-B27 positivity is strongly associated 29 with this condition. Herein, we present a case of RA favored to be triggered by the Pfizer-30

BioNTech COVID-19 mRNA vaccine (BNT162b2). pounds. 44 (Fig 1, A and B) , extensive onycholysis, nail thickening, and subungual debris of the toenails 48 (Fig 1, C) , tender edema of the right foot and joints of the right hand (Fig 3, D and E) , and a 49 scaly erythematous plaque on the penis (Fig 1, F) . Laboratory workup showed an elevated 50 erythrocyte sedimentation rate and C-reactive protein. Blood and urine cultures were negative. 51 HLA-B27 testing by flow cytometry was indeterminate. Further HLA-B27 genotyping was not 52 performed; a definitive result was therefore not obtained. Additionally, the patient tested 53 negative for syphilis, HIV, chlamydia, and gonorrhea. the stratum corneum, findings typical for a psoriasiform diathesis (Fig 2, A and B) . Small vessel 62 vasculitis of the dermal papillary microvasculature was also observed. Additional immunologic 63 stains revealed vascular deposits of C4d and C5b-9, representing classical complement pathway 64 activation as seen in an Arthus type III immune complex reaction (Fig 2, C and D) . Human 65 manufactured spike glycoprotein was identified within deep dermal microvessels (Fig 3) The extensive complement deposition in the microvasculature also highlighted the role of 105 complement pathway activation in the pathogenesis of this condition. Immune complex-106 mediated reactions have been described following infection with and vaccination against 107 COVID-19, 9 and this case further illustrates the role of complement in these circumstances. 108

The pathogenesis of hypersensitivity reactions following COVID-19 mRNA vaccination has not 110 been well established. The BNT162b2 vaccine delivers mRNA that encodes the SARS-CoV-2 111 spike protein encapsulated in a lipid particle. 4 It is therefore possible that this spike glycoprotein, 112 which is produced by myocytes upon vaccination, may act as an antigenic stimulus. In our case, 113 spike glycoprotein was indeed identified in the deep cutaneous vessels (Fig 3) . Another potential 114 trigger is the polyethylene glycol vaccine additive, a polymer that is used to stabilize the lipid 115 nanoparticle formulation. It has been suggested that this polymer, which is known to cause type I 116 hypersensitivity reactions, may also cause delayed antibody-mediated responses. 3,4 A third 117 possibility is that the vaccine may unmask a hypersensitivity reaction to an unidentified trigger, 118 such as an asymptomatic infection. Though we cannot conclusively determine whether there was 119 a causal relationship between the COVID-19 mRNA vaccine and the development of RA in our 120 patient, further investigation of rare cases such as this one will ideally enhance our understanding 121 of immune-mediated reactions to COVID-19 vaccination. 122

We thank this patient for his consent to publish this case report. We also appreciate Dr. Gerard 

Reiter's syndrome: the classic triad and more

Cutaneous reactions reported after 150

Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

The histologic and 153 molecular correlates of COVID-19 vaccine-induced changes in the skin

Clinical and 156 histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 157 vaccination

Arthritis following COVID-19 vaccination: report of two cases

INACTIVATED COVID-19 VACCINE 161 CAN INDUCE REACTIVE POLYARTHRITIS IN OLDER PATIENTS: REPORT OF 162 TWO CASES

Flare of rheumatoid arthritis after COVID-19 vaccination

Vasculitis as the basis of cutaneous lesions in 166

Reiter's disease